13F Data
13F filer · CIK 1703031

Bain Capital Life Sciences Investors, LLC

Boston, MA · filing since Q4 2017 · last filing Aug 14, 2026
Reported value
$1.7B
+$573.2M vs prior
Positions
21
New / sold out
2 / 1
Added / reduced
2 / 7
Turnover
15.5%
buys $651.2M · sells $217.0M
Top-10 weight
87.9%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewKAILERA THERAPEUTICS INC+22,583,268–+$497.5M
AddedALKERMES PLC+1,327,938+217.7%+$69.6M
NewHEMAB THERAPEUTICS HOLDINGS INC+1,650,000–+$60.6M
AddedCABALETTA BIO INC+7,564,320+78.2%+$23.5M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedNEWAMSTERDAM PHARMA COMPANY-3,500,000-47.9%$-118.6M
ReducedHEARTFLOW INC-2,000,000-19.1%$-58.7M
Sold outCENTESSA PHARMACEUTICALS-635,000-100.0%$-25.2M
ReducedOLEMA PHARMACEUTICALS INC-387,989-5.2%$-4.9M
ReducedANNEXON INC-774,943-14.9%$-4.4M
ReducedKYVERNA THERAPEUTICS INC-225,000-7.2%$-2.0M
ReducedUPSTREAM BIO INC-266,262-30.7%$-1.8M
ReducedATEA PHARMACEUTICALS INC-284,999-12.1%$-1.3M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2017: $152.4MQ1 2018: $169.6MQ2 2018: $319.1MQ3 2018: $440.6MQ4 2018: $292.6MQ1 2019: $250.1MQ2 2019: $196.9MQ3 2019: $388.4MQ4 2019: $670.5MQ1 2020: $591.3MQ2 2020: $954.8MQ3 2020: $1.1BQ4 2020: $1.6BQ1 2021: $1.8BQ2 2021: $1.5BQ3 2021: $1.6BQ4 2021: $1.3BQ1 2022: $1.0BQ2 2022: $852.7MQ3 2022: $837.8MQ4 2022: $894.8MQ1 2023: $800.1MQ2 2023: $971.0MQ3 2023: $894.2MQ4 2023: $1.0BQ1 2024: $1.2BQ2 2024: $910.8MQ3 2024: $961.2MQ4 2024: $850.1MQ1 2025: $675.9MQ2 2025: $799.3MQ3 2025: $1.5BQ4 2025: $1.3BQ1 2026: $1.1BQ2 2026: $1.7B
Q4 2017Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1KAILERA THERAPEUTICS INCCOMMON STOCK22,583,268$497.5M29.58%
2HEARTFLOW INCCOM8,448,158$247.9M14.74%
3NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES3,806,566$129.0M7.67%
4SAVARA INCCOM17,600,621$108.4M6.45%
5ALKERMES PLCSHS1,937,938$101.5M6.04%
6SOLID BIOSCIENCES INCCOM NEW9,808,819$98.0M5.83%
7PHARVARIS N VCOM2,675,509$92.5M5.50%
8OLEMA PHARMACEUTICALS INCCOM7,085,249$88.6M5.27%
9HEMAB THERAPEUTICS HOLDINGS INCCOM SHS1,650,000$60.6M3.60%
10CABALETTA BIO INCCOM17,241,445$53.6M3.19%
11 more rows. Subscribe for $29/month to see every row, download the data and use the API.